Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

NCT05808634 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Adenocarcinoma

Interventions

DRUG: BA3182

Sponsor

BioAtla, Inc.